Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
grandfather-grandson-hugging

Our purpose

Reimagine medicine to improve and extend
people's lives.

family-looking-at-sunset

Our vision

Become the most valued and trusted medicines company in the world.

group-of-women-from-indigenous-community-health-workshop-columbia

Our strategy

Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Our footprint

78k

Employees*

130

Countries**

250m+

Patients reached***

We focus on core therapeutic areas with high unmet patient needs

and technology platforms that enable cutting-edge innovative therapies

chemistry-card-blue-gradient-icon-3

Chemistry

Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines.

antibody-blue-gradient-icon

Biotherapeutics

Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.

seringue-blue-gradient-icon

xRNA

RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.

atom-blue-gradient-icon

Radioligand therapy

Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue.

gene-blue-gradient-icon

Gene and cell therapy

Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.

In this new era, we’re ready.
Together, let’s reimagine medicine to improve and extend people’s lives.

Resource Links

*Based on 2022 data except for employees which has been restated to exclude Sandoz
** Based on 2022 data, excluding Sandoz
*** Based on 2022 data, excluding Sandoz: 236 million patients reached with innovative medicines; 54 million patients reached through Novartis Global Health, which focuses on transforming health in low- and middle-income countries.